TRANXENE 15 mg, gélule
Country: France
Language: French
Source: ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
clorazépate dipotassique
Available from:
SANOFI AVENTIS FRANCE
INN (International Name):
clorazepate dipotassium
Dosage:
0,015 g
Pharmaceutical form:
gélule
Composition:
composition pour une gélule > clorazépate dipotassique : 0,015 g
Administration route:
orale
Units in package:
1 flacon(s) en verre de 30 gélule(s)
Prescription type:
liste I
Product summary:
319 214-1 ou 34009 319 214 1 7 - 1 flacon(s) en verre de 30 gélule(s) - Déclaration de commercialisation non communiquée:;
Authorization status:
Abrogée
Authorization date:
1988-07-27
